Insights

Nationwide, payors are mandating that high-cost biologic infusion care be shifted from the hospital outpatient setting to the ambulatory setting. It’s vital for every health system to have a plan in place to mitigate these payor mandates and avoid financial losses. There is increasing evidence, especially post-pandemic, that home infusion site of care management can lower costs, improve convenience, and improve the quality of patient care.

In this video, Senior Vice Presidents Steve Rough and Phil Brummond explain how Visante helps strategize site of care management to recognize margin and revenue growth opportunities, reduce costs, and improve provider and patient satisfaction.